Literature DB >> 15790942

High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose-binding lectin genotype.

Szabolcs Rugonfalvi-Kiss1, Edit Dósa, Hans O Madsen, Valéria Endrész, Zoltán Prohászka, Judit Laki, István Karádi, Eva Gönczöl, László Selmeci, László Romics, George Füst, László Entz, Peter Garred.   

Abstract

BACKGROUND AND
PURPOSE: Mannose-binding lectin (MBL) is thought to influence the pathophysiology of cardiovascular disease by decreasing the risk of advanced atherosclerosis and by contributing to enhanced ischemia reperfusion injury. Thus, we investigated the role of MBL in restenosis after eversion endarterectomy in patients with severe carotid atherosclerosis.
METHODS: In a prospective study, 123 patients who underwent carotid endarterectomy were followed-up by carotid duplex scan (CDS) sonography for 14 months. In a retrospective study, we examined 17 patients and 29 patients, respectively, who had or had not at least 50% restenosis 29 months after carotid eversion endarterectomy. MBL genotypes were analyzed by a polymerase chain reaction-based method, and MBL serum concentrations were measured.
RESULTS: In the prospective study in the patients homozygous for the normal MBL genotype, CDS values were significantly higher after 14 months of follow-up compared with the values measured 6 weeks after surgery (P<0.001). In contrast, only a slight increase was registered in patients carrying MBL variant alleles. The differences were much more pronounced in female than in male patients. Similar differences were observed when patients with high and low MBL serum concentrations were compared. In the retrospective study, a significant increase in the frequency of MBL variant genotypes was observed in patients not experiencing restenosis compared with the patients with restenosis (P=0.007).
CONCLUSIONS: These results indicate that reoccurrence of stenosis after carotid endarterectomy is partially genetically determined and imply that MBL contributes significantly to the pathophysiology of this condition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790942     DOI: 10.1161/01.STR.0000160752.67422.18

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Elevated Serum Mannose-Binding Lectin Levels Are Associated with Poor Outcome After Acute Ischemic Stroke in Patients with Type 2 Diabetes.

Authors:  Fang-Yu Song; Meng-Hai Wu; Li-Hua Zhu; Zhi-Qiang Zhang; Qin-De Qi; Chang-Li Lou
Journal:  Mol Neurobiol       Date:  2014-10-25       Impact factor: 5.590

2.  Deficiency of complement factor MBL in a patient required cardiac surgery after an acute myocardial infarction with underlining chronic lymphocytic leukemia.

Authors:  Lawrence T Lai; Daniel C Lee; Wilson Ko; Ketan Shevde; Ming Zhang
Journal:  Int J Cardiol       Date:  2008-11-26       Impact factor: 4.164

3.  Mannose-binding lectin without the aid of its associated serine proteases alters lipopolysaccharide-mediated cytokine/chemokine secretion from human endothelial cells.

Authors:  Hee Jung Kang; Sun-Mi Lee; Hyeon-Hwa Lee; Ji Yeon Kim; Byung-Chul Lee; Jung-Sun Yum; Hong Mo Moon; Bok Luel Lee
Journal:  Immunology       Date:  2007-05-22       Impact factor: 7.397

4.  The relationship between serum mannose-binding lectin levels and acute ischemic stroke risk.

Authors:  Zhen-Yu Wang; Zhong-Ren Sun; Li-Ming Zhang
Journal:  Neurochem Res       Date:  2013-12-06       Impact factor: 3.996

5.  The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery.

Authors:  Charles D Collard; Stanton K Shernan; Amanda A Fox; Toralf Bernig; Stephen J Chanock; William K Vaughn; Kazue Takahashi; Alan B Ezekowitz; Petr Jarolim; Simon C Body
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

Review 6.  New insights of an old defense system: structure, function, and clinical relevance of the complement system.

Authors:  Christian Ehrnthaller; Anita Ignatius; Florian Gebhard; Markus Huber-Lang
Journal:  Mol Med       Date:  2010-10-29       Impact factor: 6.354

7.  Restenosis and therapy.

Authors:  Laszlo Denes; Laszlo Entz; Veronika Jancsik
Journal:  Int J Vasc Med       Date:  2012-02-23

8.  Genetic and other factors determining mannose-binding lectin levels in American Indians: the Strong Heart Study.

Authors:  Lyle G Best; Robert E Ferrell; Susan Decroo; Kari E North; Jean W Maccluer; Ying Zhang; Elisa T Lee; Barbara V Howard; Jason Umans; Vittorio Palmieri; Peter Garred
Journal:  BMC Med Genet       Date:  2009-01-22       Impact factor: 2.103

9.  Mannose-Binding Lectin Levels and Carotid Intima-Media Thickness in Type 2 Diabetic Patients.

Authors:  Miklós Káplár; Shah Sweni; Julianna Kulcsár; Barbara Cogoi; Regina Esze; Sándor Somodi; Mária Papp; László Oláh; Mária Tünde Magyar; Katalin Szabó; Katalin Réka Czuriga-Kovács; Jolán Hársfalvi; György Paragh
Journal:  J Diabetes Res       Date:  2015-11-10       Impact factor: 4.011

Review 10.  ON VASCULAR STENOSIS, RESTENOSIS AND MANNOSE BINDING LECTIN.

Authors:  Barbara Stadler Kahlow; Rodrigo Araldi Nery; Thelma L Skare; Carmen Australia Paredes Marcondes Ribas; Gabriela Piovezani Ramos; Roberta Dombroski Petisco
Journal:  Arq Bras Cir Dig       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.